Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer

Clinical trial NCT02406235 · COMPLETED

Trial details

NCT number: NCT02406235
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Epithelial Ovarian/Fallopian Tube/Primary Peritoneal Cancer

Start date: 2015-04-21
Primary completion: 2016-09-30
Enrollment: 710

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.